Literature DB >> 14604550

TNF-alpha detection using a flow cytometric assay to determine cellular responses to anthrax vaccine.

Annie H Shinn1, Normita C Bravo, Holden T Maecker, James W Smith.   

Abstract

This study describes a four-color flow cytometric assay that detects CD4+ T cell responses to the anthrax vaccine. Whole blood from seven volunteers who previously obtained the anthrax vaccine was inoculated in vitro with varying concentrations of the anthrax antigen. TNF-alpha and IFN-gamma production from memory CD4+ T cells were measured and compared to a control group who never received the anthrax vaccine. The optimal antigen concentration for TNF-alpha was determined to be around 7.5 microg/ml and IFN-gamma production was not detected. This assay will be used in future larger prospective studies to further evaluate the cellular immune responses induced by the anthrax vaccine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604550     DOI: 10.1016/j.jim.2003.07.012

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Photostable single-molecule nanoparticle optical biosensors for real-time sensing of single cytokine molecules and their binding reactions.

Authors:  Tao Huang; Prakash D Nallathamby; Xiao-Hong Nancy Xu
Journal:  J Am Chem Soc       Date:  2008-12-17       Impact factor: 15.419

2.  The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.

Authors:  William W Kwok; Junbao Yang; Eddie James; John Bui; Laurie Huston; Andrew R Wiesen; Michelle Roti
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

3.  The IL-23/Th17 axis is involved in the adaptive immune response to Bacillus anthracis in humans.

Authors:  Kristina M Harris; Girish Ramachandran; Subhendu Basu; Sandra Rollins; Dean Mann; Alan S Cross
Journal:  Eur J Immunol       Date:  2014-01-02       Impact factor: 5.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.